BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 37843347)

  • 21. Mucosal Expression of Type 2 and Type 17 Immune Response Genes Distinguishes Ulcerative Colitis From Colon-Only Crohn's Disease in Treatment-Naive Pediatric Patients.
    Rosen MJ; Karns R; Vallance JE; Bezold R; Waddell A; Collins MH; Haberman Y; Minar P; Baldassano RN; Hyams JS; Baker SS; Kellermayer R; Noe JD; Griffiths AM; Rosh JR; Crandall WV; Heyman MB; Mack DR; Kappelman MD; Markowitz J; Moulton DE; Leleiko NS; Walters TD; Kugathasan S; Wilson KT; Hogan SP; Denson LA
    Gastroenterology; 2017 May; 152(6):1345-1357.e7. PubMed ID: 28132889
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of responsive gene expression as a sensitive and specific biomarker in patients with ulcerative colitis.
    Román J; Planell N; Lozano JJ; Aceituno M; Esteller M; Pontes C; Balsa D; Merlos M; Panés J; Salas A
    Inflamm Bowel Dis; 2013 Feb; 19(2):221-9. PubMed ID: 22605655
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Based on Network Pharmacology to Explore the Molecular Targets and Mechanisms of Gegen Qinlian Decoction for the Treatment of Ulcerative Colitis.
    Wei M; Li H; Li Q; Qiao Y; Ma Q; Xie R; Wang R; Liu Y; Wei C; Li B; Zheng C; Sun B; Yu B
    Biomed Res Int; 2020; 2020():5217405. PubMed ID: 33299870
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantitive cytokine mRNA expression profiles in the colonic mucosa of patients with steroid naïve ulcerative colitis during active and quiescent disease.
    Matsuda R; Koide T; Tokoro C; Yamamoto T; Godai T; Morohashi T; Fujita Y; Takahashi D; Kawana I; Suzuki S; Umemura S
    Inflamm Bowel Dis; 2009 Mar; 15(3):328-34. PubMed ID: 18942752
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Bioinformatic analysis of differentially expressed genes and Chinese medicine prediction for ulcerative colitis].
    Hu ZR; Zheng WJ; Yan Q; Hu WW; Sun XS
    Zhongguo Zhong Yao Za Zhi; 2020 Apr; 45(7):1684-1690. PubMed ID: 32489050
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unveiling the key genes, environmental toxins, and drug exposures in modulating the severity of ulcerative colitis: a comprehensive analysis.
    Wang Y; Zhuang H; Jiang XH; Zou RH; Wang HY; Fan ZN
    Front Immunol; 2023; 14():1162458. PubMed ID: 37539055
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis.
    Feagan BG; Macdonald JK
    Cochrane Database Syst Rev; 2012 Oct; 10():CD000543. PubMed ID: 23076889
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacodynamic mechanisms behind a refractory state in inflammatory bowel disease.
    Goll R; Moe ØK; Johnsen KM; Meyer R; Friestad J; Gundersen MD; Kileng H; Johnsen K; Florholmen JR
    BMC Gastroenterol; 2022 Nov; 22(1):464. PubMed ID: 36384462
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of differentially expressed genes in ulcerative colitis and verification in a colitis mouse model by bioinformatics analyses.
    Shi L; Han X; Li JX; Liao YT; Kou FS; Wang ZB; Shi R; Zhao XJ; Sun ZM; Hao Y
    World J Gastroenterol; 2020 Oct; 26(39):5983-5996. PubMed ID: 33132649
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The potential mechanism of Bletilla striata in the treatment of ulcerative colitis determined through network pharmacology, molecular docking, and in vivo experimental verification.
    Gong S; Lv R; Fan Y; Shi Y; Zhang M
    Naunyn Schmiedebergs Arch Pharmacol; 2023 May; 396(5):983-1000. PubMed ID: 36576506
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis.
    Wang Y; Parker CE; Bhanji T; Feagan BG; MacDonald JK
    Cochrane Database Syst Rev; 2016 Apr; 4(4):CD000543. PubMed ID: 27101467
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel mRNA Signature for Anti-TNF-α Therapy Primary Response in Patients With Ulcerative Colitis.
    Yang X; Shi J; Wang G; Chen H; Ye Y; Zhong J; Wang Z
    Inflamm Bowel Dis; 2023 Sep; 29(9):1458-1469. PubMed ID: 37080716
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methotrexate for induction of remission in ulcerative colitis.
    Chande N; Wang Y; MacDonald JK; McDonald JW
    Cochrane Database Syst Rev; 2014 Aug; 2014(8):CD006618. PubMed ID: 25162749
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of diagnostic signatures in ulcerative colitis patients via bioinformatic analysis integrated with machine learning.
    Lu J; Wang Z; Maimaiti M; Hui W; Abudourexiti A; Gao F
    Hum Cell; 2022 Jan; 35(1):179-188. PubMed ID: 34731452
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeted Assessment of Mucosal Immune Gene Expression Predicts Clinical Outcomes in Children with Ulcerative Colitis.
    Clarkston K; Karns R; Jegga AG; Sharma M; Fox S; Ojo BA; Minar P; Walters TD; Griffiths AM; Mack DR; Boyle B; LeLeiko NS; Markowitz J; Rosh JR; Patel AS; Shah S; Baldassano RN; Pfefferkorn M; Sauer C; Kugathasan S; Haberman Y; Hyams JS; Denson LA; Rosen MJ
    J Crohns Colitis; 2022 Nov; 16(11):1735-1750. PubMed ID: 35665804
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Revealing the mechanism of "Huai Hua San" in the treatment of ulcerative colitis based on network pharmacology and experimental study.
    Chen PY; Yuan C; Hong ZC; Zhang Y; Ke XG; Yu B; Wang C; Xiao XC; Wu HZ; Yang YF
    J Ethnopharmacol; 2021 Dec; 281():114321. PubMed ID: 34118340
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of molecular subgroups in osteomyelitis induced by staphylococcus aureus infection through gene expression profiles.
    Shi X; Ni H; Tang L; Li M; Wu Y; Xu Y
    BMC Med Genomics; 2023 Jun; 16(1):149. PubMed ID: 37370094
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation of Biomarker Expression in Colonic Mucosa with Disease Phenotype in Crohn's Disease and Ulcerative Colitis.
    Bruno ME; Rogier EW; Arsenescu RI; Flomenhoft DR; Kurkjian CJ; Ellis GI; Kaetzel CS
    Dig Dis Sci; 2015 Oct; 60(10):2976-84. PubMed ID: 25956706
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification and exploration of pharmacological pyroptosis-related biomarkers of ulcerative colitis.
    Chen K; Shang S; Yu S; Cui L; Li S; He N
    Front Immunol; 2022; 13():998470. PubMed ID: 36311726
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ulcerative colitis impairs the acylethanolamide-based anti-inflammatory system reversal by 5-aminosalicylic acid and glucocorticoids.
    Suárez J; Romero-Zerbo Y; Márquez L; Rivera P; Iglesias M; Bermúdez-Silva FJ; Andreu M; Rodríguez de Fonseca F
    PLoS One; 2012; 7(5):e37729. PubMed ID: 22662201
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.